Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 159

Similar articles for PubMed (Select 24347475)

1.

Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times.

Squires MH 3rd, Hanish SI, Fisher SB, Garrett C, Kooby DA, Sarmiento JM, Cardona K, Adams AB, Russell MC, Magliocca JF, Knechtle SJ, Staley CA 3rd, Maithel SK.

J Surg Oncol. 2014 May;109(6):533-41. doi: 10.1002/jso.23531. Epub 2013 Dec 17.

2.

Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?

Koniaris LG, Levi DM, Pedroso FE, Franceschi D, Tzakis AG, Santamaria-Barria JA, Tang J, Anderson M, Misra S, Solomon NL, Jin X, DiPasco PJ, Byrne MM, Zimmers TA.

Ann Surg. 2011 Sep;254(3):527-37; discussion 537-8. doi: 10.1097/SLA.0b013e31822ca66f.

3.

Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis.

Sourianarayanane A, El-Gazzaz G, Sanabria JR, Menon KV, Quintini C, Hashimoto K, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F.

HPB (Oxford). 2012 May;14(5):325-32. doi: 10.1111/j.1477-2574.2012.00453.x. Epub 2012 Mar 27.

4.

Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.

Taura K, Ikai I, Hatano E, Yasuchika K, Nakajima A, Tada M, Seo S, Machimoto T, Uemoto S.

Surgery. 2007 Nov;142(5):685-94.

PMID:
17981188
5.

Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.

Jiang L, Liao A, Wen T, Yan L, Li B, Yang J.

Transpl Int. 2014 Jun;27(6):562-9. doi: 10.1111/tri.12297. Epub 2014 Apr 2.

PMID:
24606007
6.

Hepatic resection for transplantable hepatocellular carcinoma for patients within Milan and UCSF criteria.

Chua TC, Saxena A, Chu F, Morris DL.

Am J Clin Oncol. 2012 Apr;35(2):141-5. doi: 10.1097/COC.0b013e318209ab7d.

PMID:
21336092
8.

Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.

Franssen B, Alshebeeb K, Tabrizian P, Marti J, Pierobon ES, Lubezky N, Roayaie S, Florman S, Schwartz ME.

Ann Surg. 2014 Oct;260(4):650-6; discussion 656-8. doi: 10.1097/SLA.0000000000000917.

PMID:
25203882
9.

Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.

Teh SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M, Cha S, Kamath P, Kim R, Nagorney DM.

J Gastrointest Surg. 2005 Dec;9(9):1207-15; discussion 1215.

PMID:
16332475
10.

Role of surgical resection for multiple hepatocellular carcinomas.

Choi SH, Choi GH, Kim SU, Park JY, Joo DJ, Ju MK, Kim MS, Choi JS, Han KH, Kim SI.

World J Gastroenterol. 2013 Jan 21;19(3):366-74. doi: 10.3748/wjg.v19.i3.366.

11.

Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation.

Kim PT, Onaca N, Chinnakotla S, Davis GL, Jennings LW, McKenna GJ, Ruiz RM, Levy MF, Goldstein R, Klintmalm GB.

Clin Transplant. 2013 Mar-Apr;27(2):311-8. doi: 10.1111/ctr.12089. Epub 2013 Jan 28.

PMID:
23351129
12.

Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions.

Schmitt TM, Kumer SC, Shah N, Argo CK, Northup PG.

Ann Hepatol. 2010 Oct-Dec;9(4):390-6.

PMID:
21057157
13.
14.

Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention-to-treat principle.

Foltys D, Zimmermann T, Kaths M, Strempel M, Heise M, Hoppe-Lotichius M, Weiler N, Scheuermann U, Ruckes C, Hansen T, Pitton M, Otto G.

Clin Transplant. 2014 Jan;28(1):37-46. doi: 10.1111/ctr.12273. Epub 2013 Oct 31.

PMID:
24171713
15.

Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?

Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, Samuel D, Bismuth H.

Ann Surg. 2003 Oct;238(4):508-18; discussion 518-9.

16.

Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.

Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS Jr, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.

Hepatology. 2011 Oct;54(4):1313-21. doi: 10.1002/hep.24494.

17.

Histological differentiation predicts post-liver transplantation survival time.

Li WX, Li Z, Gao PJ, Gao J, Zhu JY.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):201-8. doi: 10.1016/j.clinre.2013.11.002. Epub 2013 Dec 30.

PMID:
24388339
18.

Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.

Porrett PM, Peterman H, Rosen M, Sonnad S, Soulen M, Markmann JF, Shaked A, Furth E, Reddy KR, Olthoff K.

Liver Transpl. 2006 Apr;12(4):665-73.

19.

Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.

Dahiya D, Wu TJ, Lee CF, Chan KM, Lee WC, Chen MF.

Surgery. 2010 May;147(5):676-85. doi: 10.1016/j.surg.2009.10.043. Epub 2009 Dec 11.

PMID:
20004441
20.

Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection.

Zhu WJ, Huang CY, Li C, Peng W, Wen TF, Yan LN, Li B, Wang WT, Xu MQ, Yang JY, Jiang L.

Asian Pac J Cancer Prev. 2013;14(12):7101-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk